Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1783 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Siegfried To Create Functional Organization

Rudolf Hanko, CEO of Siegfried, said: “Siegfried is one of the rare suppliers of the pharmaceutical industry that is capable of providing both the chemical synthesis of active

FDA Accepts Teva’s BLA For XM02

XM02 is a granulocyte colony-stimulating factor (G-CSF) for reducing the duration of severe neutropenia and the incidence of febrile neutropenia, in patients treated with established myelosuppressive chemotherapy for